Literature DB >> 25832165

Is research ethics regulation really killing people?

David Hunter1.   

Abstract

It has been argued that research ethics regulation is leading to loss of life by delaying life-saving research. For example, Whitney and Schneider argue that the delays to the ISIS-2 trial cost 6538 lives. This suggests that there are grounds for rejecting research ethics regulation. However, the methods adopted by critics are flawed because: they conflate regulatory delays with those due to genuine normative requirements that would be present even if the regulatory framework was not; and looking at the impact of regulation on a per-project basis is the wrong metric, because it neglects all the unsuccessful research and because delaying specific projects does not reduce the overall research done by researchers. Research ethics regulation does not lead to substantial losses of life, but we have strong obligations to make it as efficient as possible.

Entities:  

Mesh:

Year:  2015        PMID: 25832165     DOI: 10.5694/mja14.00338

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Heterogeneity of Human Research Ethics Committees and Research Governance Offices across Australia: An observational study.

Authors:  Elisabeth De Smit; Lisa S Kearns; Linda Clarke; Jonathan Dick; Catherine L Hill; Alex W Hewitt
Journal:  Australas Med J       Date:  2016-02-29

2.  Huge variation in obtaining ethical permission for a non-interventional observational study in Europe.

Authors:  Dylan W de Lange; Bertrand Guidet; Finn H Andersen; Antonio Artigas; Guidio Bertolini; Rui Moreno; Steffen Christensen; Maurizio Cecconi; Christina Agvald-Ohman; Primoz Gradisek; Christian Jung; Brian J Marsh; Sandra Oeyen; Bernardo Bollen Pinto; Wojciech Szczeklik; Ximena Watson; Tilemachos Zafeiridis; Hans Flaatten
Journal:  BMC Med Ethics       Date:  2019-06-03       Impact factor: 2.652

3.  Australian general practitioner perceptions to sharing clinical data for secondary use: a mixed method approach.

Authors:  Richard J Varhol; Sean Randall; James H Boyd; Suzanne Robinson
Journal:  BMC Prim Care       Date:  2022-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.